Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Meningioma · Glioblastoma · Acoustic Neuroma · Brain Cancer · Pituitary Adenoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

Study leads
  • Peter Morone, MD

    Principal Investigator

    Vanderbilt University Medical Center